A High Calcium Is Not a Fluke: Finding Primary Hyperparathyroidism

This post walks the finding from the top: why a mildly high calcium gets waved off, the paired result that makes the diagnosis, the mimics and how each is separated out, what untreated disease does to bone and kidney, and the criteria that move it to surgery. Most people with this feel fine. That is the problem, not the reassurance.

Why a slightly high calcium keeps getting waved off

Primary hyperparathyroidism is the leading cause of high calcium in the outpatient setting, and the modern presentation has little in common with the textbook version (per NIH/NCBI StatPearls). Screening panels find it long before it announces itself, so bone pain, fractures, and stones have largely been replaced by an incidental hypercalcemia in someone who feels ordinary. Age-adjusted prevalence in a large US health-system cohort was estimated at 233 per 100,000 women and 85 per 100,000 men in 2010, with a female to male ratio around 3:1 to 4:1 and a peak between ages 50 and 60 (NIH/NCBI).

So the typical patient is a postmenopausal woman with a calcium of 10.5 and no complaints. Nothing about that demands attention on the day it appears. It only becomes loud lined up against five years of the same value, and that lining-up is exactly the work that falls through the gap between a family doctor, a specialist, and two lab portals. Our piece on why normal describes a population, not you makes the general version of this point.

The two results that have to be read together

Here is the diagnosis in one line. Primary hyperparathyroidism is elevated albumin-adjusted serum calcium alongside an elevated or inappropriately normal intact parathyroid hormone, on two occasions at least two weeks apart (Fifth International Workshop, 2022). The albumin adjustment matters: calcium travels partly bound to albumin, so a low albumin can make a genuinely high calcium read as normal.

The word doing the work is "inappropriately". Healthy parathyroid glands watch the blood calcium and shut off when it rises. That is their only job. So a PTH sitting mid-range while calcium is high is not a normal PTH. It is a gland that has stopped listening. Cases hide behind exactly that pattern: the two values are read separately, each looks acceptable alone, and the contradiction between them is never assembled.

The cause is usually small and benign. A single parathyroid adenoma accounts for 80% to 85% of cases, multigland disease for 10% to 15%, and parathyroid carcinoma for well under 1% (NIH/NCBI). There is also a normocalcemic variant, normal adjusted and ionized calcium with a genuinely elevated PTH, for which the Fifth International Workshop says the data are too limited to recommend surgical guidelines (2022).

What else pushes calcium up, and how each one is separated out

A high calcium plus a high PTH narrows the field fast, but it does not close it. Four things have to be actively ruled out, and each has its own tell.

• Thiazide diuretics. Thiazides cut urinary calcium excretion and can produce a mild hypercalcemia, but they often unmask underlying disease rather than cause it: in a Mayo Clinic series, hypercalcemia persisted in 21 of 33 patients (64%) after the thiazide was stopped (Wermers et al., The American Journal of Medicine 2007), and in the larger follow-up of the same cohort 71% had persistent hypercalcemia and 24% were diagnosed with primary hyperparathyroidism (Griebeler et al., The Journal of Clinical Endocrinology and Metabolism 2016). The calcium is rechecked after the drug is stopped; the file does not close the moment the drug is spotted.
• Lithium. Lithium shifts the set point of the calcium and PTH relationship, making the glands less sensitive to calcium and raising both values. Anyone on long-term lithium with a high calcium needs that considered before a surgeon is called.
• Familial hypocalciuric hypercalcemia (FHH). The mimic that matters most, because the mistake it produces is an operation. FHH is autosomal dominant, caused by a loss-of-function mutation in the calcium-sensing receptor gene, and it gives lifelong mild hypercalcemia with a normal or slightly high PTH. The urine points the way but does not settle it: suspect it in younger people with a urinary calcium to creatinine clearance ratio below 0.01 or a family history of hypercalcemia, and test genetically when it is considered (Fifth International Workshop, 2022). Roughly 40% of people with either condition sit in the 0.01 to 0.02 grey zone, which is why genetic testing and not the ratio is what resolves it. It is benign, fracture incidence is not increased, and parathyroid surgery does not correct it (NIH/NCBI).
• Malignancy. The other common cause, and it behaves differently. The calcium is usually driven by tumor-derived parathyroid hormone-related peptide, so the patient's own PTH is low to normal rather than elevated, the calcium is often higher and more symptomatic at presentation, and it often occurs in advanced disease, though hypercalcemia can also be the first sign of a cancer not yet diagnosed (NIH/NCBI). That sits with the other remote effects a tumor can produce, covered in paraneoplastic syndromes and hidden cancer.

None of this is settled by more calcium levels. It is settled by the partners: PTH, 25-hydroxyvitamin D, phosphorus, creatinine, and a 24-hour urine (Fifth International Workshop).

What it is quietly doing to bone and kidney

"You feel fine" is not the end of it, because both main consequences are silent until they are not.

Excess parathyroid hormone pulls calcium out of bone, which is why untreated disease weakens the skeleton (per NIH/NCBI). The pattern is easy to miss: in a 15-year observational study, lumbar spine density stayed stable while cortical sites fell, dropping roughly 10% at the femoral neck and about 35% at the distal radius in the patients followed longest (published in The Journal of Clinical Endocrinology and Metabolism, 2008). That is why the recommended scan is a three-site DXA including the distal one-third radius (Fifth International Workshop, 2022). Scan the wrong two sites and the disease looks like it is doing nothing.

The kidney side is just as quiet. High blood calcium raises urinary calcium, which can form hard deposits in the kidneys called kidney stones (per NIH/NCBI). Up to 55% of patients show subclinical nephrocalcinosis or non-obstructing stones on imaging despite no symptoms (NIH/NCBI).

And it moves. In that same 15-year study, 37% of asymptomatic patients developed at least one new indication for surgery during observation. The majority did not. Neither half is knowable in advance without measuring.

When surgery is the answer, and when watching is

Anyone with symptomatic disease should be offered parathyroid surgery unless it is medically contraindicated (Fifth International Workshop, 2022). For asymptomatic disease, meeting any one of these triggers is enough:

• Serum calcium more than 1 mg/dL (0.25 mmol/L) above the upper limit of normal.
• A vertebral fracture on X-ray or vertebral fracture assessment, or a bone mineral density T-score of -2.5 or lower at any site.
• eGFR or creatinine clearance below 60 mL/min, nephrocalcinosis or nephrolithiasis on imaging, or 24-hour urinary calcium above 250 mg/day in women or above 300 mg/day in men.
• Age under 50, sufficient on its own with no other criteria required.

Surgery stays an option for people who meet none of these, if they and their physician agree. Parathyroidectomy is the only definitive treatment, with cure rates above 95% in experienced centers, improvement in bone density that is sustained for more than a decade, and improvement in renal function (NIH/NCBI).

If surgery is not done, monitoring is not nothing: annual serum calcium and 25-hydroxyvitamin D, annual creatinine clearance, and a three-site DXA every one to two years unless the density is normal (Fifth International Workshop, 2022). Every criterion above is a threshold you cross only if somebody is measuring.

How Healz reads a high calcium that keeps coming back

A high calcium is a question, and the answer is almost never in the calcium. Healz is equipped with root-cause technology, so a value that keeps coming back slightly high is treated as a hypothesis to test, not a result to file. It cross-checks your case against more than a million rare cases and drills past the easy explanations (the thiazide, the dehydration, the shrug) to what is driving the number, including the familial mimic that surgery cannot fix.

The rest of the panel is read in the same place. As a blood test ai analyzer and ai lab report reader, Healz is equipped to read calcium, PTH, phosphorus, vitamin D, creatinine, and the urine collection together, so the pair that makes this diagnosis is read as a pair. Frontier AI works your case, so a technically normal PTH beside a high calcium is flagged as the contradiction it is. Healz has memory that keeps every panel you upload and tracks the calcium line across years, so a value mildly high since three physicals ago appears as a trend, not a surprise. Everything in one place, one chat, not ten apps and four portals. When you want a human in the loop, you can bring a board-certified doctor into the same chat for a second opinion.